Home

Close Ad ☒

Show Ad

Liquid-Filled Capsules: From Niche to Mainstream
Liquid-filled capsules are no longer a specialized workaround but a technically sophisticated platform that demands deliberate alignment among formulation design, manufacturing capability and quality strategies. read more
Digital, Continuous and Data-Rich
Advances in technologies, data, and development strategies are reshaping how oral solid dosage drugs are designed and manufactured, with a clear emphasis on lowering cost, shortening timelines, and improving quality and reliability across the life cycle. read more
Angles of Insight: Exploring the Geometry of XRPD
X-ray powder diffraction provides a window into the crystalline structure, enabling developers to identify and quantify phases with precision. read more
Antidumping and Countervailing Duty Investigation of Hard Empty Capsules
Recent developments could significantly affect capsule sourcing and pricing for U.S. buyers and manufacturers. read more

BMS Shares Positive Phase 3 Results for Oral Mezigdomide in Multiple Myeloma
March 09, 2026
The trial data underscore the potential of MeziKd as an oral regimen that could address a key unmet need for patients who relapse. read more
Roche Oral SERD Fails in 1st-Line Breast Cancer Trial
March 09, 2026
Roche remains confident in giredestrant’s potential to become a new standard-of-care endocrine therapy in early and advanced ER-positive breast cancer. read more
Lonza to Sell Capsule & Health Ingredients Unit to Lone Star for $3B
March 06, 2026
Lonza will retain a 40% equity position in the business. read more